Register Login
Register to leave comments
  • News bot Aug. 28, 2026, 12:32 p.m.

    📋 IBIO, INC. (IBIO) - Financial Results

    Filing Date: 2026-08-28

    Accepted: 2026-08-28 08:30:48

    Event Type: Financial Results

    Event Details:

    IBIO, INC. (IBIO) Reports the reporting period Financial Results IBIO, INC. (IBIO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 100
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 56395
      • targeting both AMY1 and AMY3, and dual amylin and calcitonin receptor agonists. Candidates are advancing through preclinical characterization to identify the pharmacologic profiles best suited to the treatment of obesity and metabolic disease.Corporate DevelopmentsFinancing and Capital Resources●Closed a public offering in August 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Revenue 100.00 100.00 $0.00 +0.00%
    Other Income Expense Interest Income 2.15K 2.15K $0.00 +0.00%
    Other Income Expense Interest Expense -53.00 -53.00 $0.00 +0.00%
    Net Loss -33.04K -33.04K $0.00 +0.00%
    Comprehensive Loss Net Loss -33.04K -33.04K $0.00 +0.00%
    Accounts Receivable Trade Net Of Allowance For Credit Losses Of And As Of June And June Respectively Prepaid Expenses Other Current Assets 3.08K 3.08K $0.00 +0.00%
    Current Liabilities Accounts Payable 4.42K 4.42K $0.00 +0.00%
    Revenue 100.00 100.00 $0.00 +0.00%
    Interest Income 2.15K 2.15K $0.00 +0.00%
    Interest Expense -53.00 -53.00 $0.00 +0.00%
    Net Loss -33.04K -33.04K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 3.08K 3.08K $0.00 +0.00%
    Intangible Assets, Net 1.82K 1.82K $0.00 +0.00%
    Accounts Payable 4.42K 4.42K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: IBIO, INC.
    • Ticker Symbol: IBIO

Search

News categories